Top25-SA-Banner

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viewray (VRAY) and Stryker Corporation (SYK)


Analysts have been eager to weigh in on the Healthcare sector with new ratings on Viewray (VRAY) and Stryker Corporation (SYK).

Viewray (VRAY)

In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Viewray, with a price target of $20. The company’s shares opened today at $7.63.

According to TipRanks.com, Kalia is a 5-star analyst with an average return of 12.4% and a 59.9% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Obalon Therapeutics Inc, and Apollo Endosurgery Inc.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Viewray with a $15.06 average price target, a 97.4% upside from current levels. In a report released today, Mizuho Securities also maintained a Buy rating on the stock.

.

See today’s analyst top recommended stocks >>

Stryker Corporation (SYK)

In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on Stryker Corporation, with a price target of $175. The company’s shares opened today at $171.

Bijou noted:

“. SYK held its analyst day meeting yesterday (11/9). The meeting focused on three of SYK’s segments – Neurovascular, Trauma & Extremities and Endoscopy. In addition, SYK highlighted its Growth (CTG) and overall financial outlook. We remain impressed with SYK’s top-line performance and believe that the diversity of the business ensures that accelerating growth in one business should offset softer growth in any particular quarter. We remain on the sidelines as we think SYK is appropriately valued and given the high expectations, it is difficult to see SYK deliver significant upside to its consensus estimates.”

According to TipRanks.com, Bijou is a 4-star analyst with an average return of 15.3% and a 74.2% success rate. Bijou covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Ra Medical Systems Inc, and Integra Lifesciences.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Stryker Corporation with a $188.57 average price target, representing a 10.3% upside. In a report issued on October 26, Needham also maintained a Hold rating on the stock.

.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.